Gene57787
MARK4: microtubule affinity regulating kinase 4
Cite this record
ConductScience Library. MARK4: microtubule affinity regulating kinase 4. Genes, record 57787. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/57787
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q96L34 | MAP/microtubule affinity-regulating kinase 4 | 752 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents81
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260193644 A1 | 2026-07-09 | 1703 | Q96L34 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 2552 | Q96L34 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 52628 | Q96L34 | Espacenet |
| JP 2026000906 A | 2026-01-06 | 105 | Q96L34 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 2132 | Q96L34 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1703 | Q96L34 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 2132 | Q96L34 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 2552 | Q96L34 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 2552 | Q96L34 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 2552 | Q96L34 | Espacenet |
NIH grants555
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MARK4 papers | Newest fiscal year |
|---|---|---|---|
| U24AG021886 | National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) | 6 | 2025 |
| P01CA120964 | Molecular Pathogenesis of the Hamartoma Syndromes | 2 | 2025 |
| P30AG072980 | Arizona Alzheimer's Disease Research Center | 2 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
| P30CA014195 | Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 2 | 2025 |
| R01AG069900 | Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models | 2 | 2025 |
| R01NS017950 | Precursors of Stroke Incidence and Prognosis | 2 | 2025 |
| R01NS115144 | Genome-Wide Prediction of Dementia in Parkinson's Disease | 2 | 2025 |
| F30AG080885 | Computational drug repurposing for Alzheimer's disease | 1 | 2025 |
Source NIH's project files
Papers561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated analysis identified MARK4 as a prognostic and immunomodulatory biomarker in oral squamous cell carcinoma. | Oncol Lett | 2026 | 42798865 | PubTator, text mining | PubMed |
| Modeling Synaptic Maturation From Growth Cone to Synapse in Human Organoids. | J Neurochem | 2026 | 42108706 | PubTator, text mining | PubMed |
| Targeting microglia microtubules: cytoskeletal remodeling as a druggable hub in neuroinflammation and neurodegeneration. | Front Neurosci | 2026 | 42088827 | PubTator, text mining | PubMed |
| Targeting of MARK2, but not other MARKs, suppresses TNBC progression by inhibition of the mutant p53-driven signaling pathway. | Chin J Nat Med | 2026 | 42019995 | PubTator, text mining | PubMed |
| Beyond microtubule regulation: the multifaceted roles of tau in neuronal function and dysfunction. | Transl Psychiatry | 2026 | 41916933 | PubTator, text mining | PubMed |
| Programmed cell death: a promising management for Alzheimer's disease. | Apoptosis | 2026 | 41904723 | PubTator, text mining | PubMed |
| Diverse Scaffolds Facilitate NLRP3 Clustering and Inflammasome Formation in Response to Perturbations in Cell Homeostasis. | Bioessays | 2026 | 41879501 | PubTator, text mining | PubMed |
| Discovery of Covalent Ligands with AlphaFold3. | J Am Chem Soc | 2026 | 41857796 | PubTator, text mining | PubMed |
| The NLRP3 Inflammasome: Mechanisms of Activation, Regulation, and Therapeutic Opportunities. | MedComm (2020) | 2026 | 41799937 | PubTator, text mining | PubMed |
| Ligand-Based Pharmacophore Mapping and Virtual Screening for the Search of Biguanide-Like Molecules With Antidiabetic Potentials Targeting Liver Kinase B1. | Biochem Res Int | 2026 | 41725923 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/57787
GET https://conductscience.org/api/genes/v1/57787/patents?page=2